Overview of the Division
Established in 2007, the Division of Experimental Neuroscience (DEN) in the Department of Clinical Neurosciences (DCNS) currently consists of five primary and five secondary members. Research areas span from neurodegenerative diseases and movement disorders, to multiple sclerosis and specialized medical device development. Almost all members within DEN maintain meaningful and productive collaborations with clinicians or clinician scientists within the department, in addition to our partners in the Hotchkiss Brain Institute (HBI), The University of Calgary and Alberta Health Services.
Dr. Bin Hu is leading a basic research program on epigenetic regulation of auditory cortex development in autism and a experimental therapeutic program on sensorimotor contingency-based music walking program for parkinson’s patients. His research is funded by Alberta Innovates - Health Sciences (AIHS), the Canadian Institutes of Health Research (CIHR), Parkinson’s Society Alberta and Suter Professorship for Parkinson’s disease research and Rose Family Endowment funds.
Dr. Minh Dang Nguyen is leading major research programs on the roles of two cytoskeletal proteins (Ndel1 and P600) in neuronal development and neurodegeneration. His research is funded by multiple grant agencies including Alberta Heritage Foundation
for Medical Research (AHFMR), Alberta Innovates - Health Sciences (AIHS), the Canadian Institutes of Health Research (CIHR), the Human Frontier Science Program Organization (HFSPO), the Brenda Strafford Foundation Chair in Alzheimer research, the Amyotrophic Lateral Sclerosis, the Multiple Sclerosis Society of Canada, the ABIP/NEAT Network, and the Austrian Academy of Sciences.
Dr. Shalina Ousman is leading a research program on studying the role of alphaB crystalline in multiple sclerosis. Her research is funded by multiple external agencies including Canadian Institutes for Health Research (CIHR), Alberta Innovates Health Solutions, and the Multiple Sclerosis Society of Canada. She was named as one of the, Top 40 Under 40, by Avenue Magazine. Dr. V. Wee Yong is leading three major research programs that investigate the roles of neuroinflammation in multiple sclerosis, spinal cord injury and brain tumors. He is elected as a fellow of the Canadian Academy of Health Sciences. This is considered one of the highest honors for members
of the Canadian Health Sciences community. His research is funded by multiple external agencies including Canadian Institutes for Health Research (CIHR), Alberta Innovates Health Solutions, Multiple Sclerosis Society of Canada and Neuroscience Canada.
The music walking program developed by Dr. Bin Hu has now expanded to six Canadian cities. It has been cited recently by the Parliamentary Committee of Canadian Government as an example of successful translational research.
The Department of Clinical Neurosciences is rapidly growing -- not only in terms of personnel and research support, but in the national and international recognition of its research achievements. Over 15 post-doctoral fellows, graduate students, and support staff are directly involved in the research conducted by DEN faculty members. In addition to this, our members continue to work in state-of-the-art research facilities, including the newly established T. Boone Pickens Centre for Neurological Science and Advanced Technologies. Education
DEN members offer graduate studies in both clinical and basic neurosciences, year-round research projects for senior undergraduates, and summer research programs. Division members are also active participants in community-oriented educational events.
The Division of Experimental Neuroscience is in a unique position to foster neuroscience research which translates into innovative health solutions. We are somewhat different from the basic science departments in that our research has a clear mandate to facilitate and integrate care, research and education. We ensure discoveries in basic and clinical research can quickly lead to innovative health solutions for Canadians who suffer from neurological and mental disorders.
Date Updated: 2013-02-02